Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion

[1]  Jean Jakoncic,et al.  Migrastatin analogues target fascin to block tumour metastasis , 2011, Nature.

[2]  Xiao-nan Wang,et al.  miR‐340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c‐Met , 2011, Cancer.

[3]  W. De,et al.  MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14) , 2011, Oncogene.

[4]  Xianqun Fan,et al.  Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene , 2011, Cancer.

[5]  Masayuki Kano,et al.  miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma , 2010, International journal of cancer.

[6]  Yan Wang,et al.  MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis , 2010, BMC Cancer.

[7]  H. Lodish,et al.  Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Feng Tian,et al.  Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation. , 2010, Cancer letters.

[9]  N. Seki,et al.  821 MIR-145 AND MIR-133A FUNCTION AS TUMOUR SUPPRESSORS AND DIRECTLY REGULATE FSCN1 EXPRESSION IN BLADDER CANCER , 2010 .

[10]  L. Liu,et al.  Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  N. Seki,et al.  miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer , 2010, British Journal of Cancer.

[12]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[13]  R. Lloyd,et al.  MicroRNA Expression in Ileal Carcinoid Tumors: Down-regulation of MicroRNA-133a with Tumor Progression , 2009, Modern Pathology.

[14]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[15]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[16]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[17]  H. Hollema,et al.  Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma , 2009, BMC Cancer.

[18]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[19]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2008, Nature.

[20]  R. Stallings,et al.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. , 2007, Cancer research.

[21]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[22]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[25]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[26]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[27]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[28]  S. Tsunoda,et al.  Prognostic Significance of Fascin Overexpression in Human Esophageal Squamous Cell Carcinoma , 2005, Clinical Cancer Research.

[29]  Josephine C. Adams,et al.  The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  M. Imamura,et al.  The Prognostic Relevance of Fascin Expression in Human Gastric Carcinoma , 2004, Oncology.

[31]  Josephine C. Adams,et al.  Fascin protrusions in cell interactions. , 2004, Trends in cardiovascular medicine.

[32]  C. Verschraegen,et al.  Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors , 2004, Clinical & Experimental Metastasis.

[33]  K. Taira,et al.  Retraction: Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells , 2003, Nature.

[34]  Josephine C. Adams,et al.  Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. , 2003, The American journal of pathology.

[35]  Josephine C. Adams,et al.  Fascins, and their roles in cell structure and function. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[37]  H. Ji,et al.  C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines , 2000, Oncogene.

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  F. Matsumura,et al.  Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. , 1998, Molecular biology of the cell.

[40]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[41]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.